Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice
about
The effect of erythropoietin on normal and neoplastic cells.Therapeutic Potential of Adipose-Derived SSEA-3-Positive Muse Cells for Treating Diabetic Skin UlcersPrevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin.A novel EPO receptor agonist improves glucose tolerance via glucose uptake in skeletal muscle in a mouse model of diabetesEffect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.Erythropoietin: still on the neuroprotection roadNeuritic dystrophy and neuronopathy in Akita (Ins2(Akita)) diabetic mouse sympathetic gangliaNeuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons.Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.Schwann cells as a therapeutic target for peripheral neuropathies.Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.The lack of CD131 and the inhibition of Neuro-2a growth by carbamylated erythropoietin.Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter elementCarbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy.Carbamylated erythropoietin ameliorates hypoxia-induced cognitive and behavioral defects with the generation of choline acetyltransferase-positive neurons.
P2860
Q34291437-9372E4E8-1CB8-4653-83E6-75BEBF9C9789Q34456751-34D0797E-81E8-4534-84DC-41EBD94AC858Q34556841-EDF719F1-4CEE-4BC9-8810-7C46410E7F17Q35094217-3DD5B32A-571A-4C40-9BF4-9F1509307DF6Q35448895-D18E0538-CF37-4934-8A3F-BE2816A305FEQ35949322-CA21FBFA-EB7F-4B89-B8FB-CC474FF534ECQ37167206-34CCD5F7-7211-4D8D-A92B-794DAC61BD26Q37300232-8F081BA4-B95F-41EB-82BB-58D2599E4717Q37358669-CC7F51EE-980F-4F81-B248-E738FBECCE7AQ37793315-EF954A91-E823-4A85-84D7-208B9E69D974Q38751058-920B2C61-18D1-44AC-B71E-9769A10CA440Q38912443-1CCC6DEC-DD47-4B7A-8F46-B5D66C33DF98Q39442049-E6BEFA97-60D9-4500-9464-60DEEF89597AQ41773498-A047137F-1EB9-4B75-A3F8-B7EC5F73A124Q44956691-1AD7C81D-339A-4DE1-8747-D4BDAAADE877
P2860
Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@ast
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@en
type
label
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@ast
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@en
prefLabel
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@ast
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@en
P2093
P2860
P1476
Erythropoietin and its carbamy ...... induced diabetic NOD-SCID mice
@en
P2093
Curtis A Parvin
Denise A Dorsey
Dongyan Feng
Jin-Moo Lee
Karen G Green
Michael Brines
Qinlgi Xiao
Robert E Schmidt
P2860
P304
P356
10.1016/J.EXPNEUROL.2007.09.018
P407
P577
2007-10-29T00:00:00Z